Noninvasive Peripheral Venous Studies

Size: px
Start display at page:

Download "Noninvasive Peripheral Venous Studies"

Transcription

1 Nninvasive Peripheral Venus Studies Nridian Healthcare Slutins, LLC Please Nte: This is a Prpsed LCD. Prpsed LCDs are wrks in prgress and nt necessarily a reflectin f the current plicies r practices. Prpsed LCDs in an apprval status display n the CMS MCD fr public review. Cntractr Infrmatin Cntractr Name Nridian Healthcare Slutins, LLC Cntract Number Cntract Type A and B MAC Assciated Cntract Numbers Prpsed LCD Infrmatin (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC, (A and B MAC J - F) Nridian Healthcare Slutins, LLC 1

2 Prpsed LCD ID Prpsed LCD Versin Prpsed LCD Title DL Nninvasive Peripheral Venus Studies CPT nly cpyright American Medical Assciatin. All rights reserved. AMA CPT ADA CDT AHA NUBC Cpyright Statements CDT nly cpyright 2016 American Dental Assciatin. All rights reserved. UB-04 Manual. OFFICIAL UB-04 DATA SPECIFICATIONS MANUAL, 2014, is cpyrighted by American Hspital Assciatin ("AHA"), Chicag, Illinis. N prtin f OFFICIAL UB-04 MANUAL may be reprduced, srted in a retrieval system, r transmitted, in any frm r by any means, electrnic, mechanical, phtcpying, recrding r therwise, withut prir express, written cnsent f AHA. Health Frum reserves the right t change the cpyright ntice frm time t time upn written ntice t Cmpany. Scial Security Act (Title XVIII) Standard References: Title XVIII f the Scial Security Act, Sectin 1862(a)(1)(A) states that n Medicare payment shall be made fr items r services which are nt reasnable and necessary fr the diagnsis r treatment f illness r injury. CMS Natinal Cverage Plicy Title XVIII f the Scial Security Act, Sectin 1862(a)(7). This sectin excludes rutine physical examinatins. Title XVIII f the Scial Security Act, Sectin 1833(e) states that n payment shall be made t any prvider fr any claim that lacks the necessary infrmatin t prcess the claim. 2

3 Title XVIII f the Scial Security Act, Sectin 1862(a)(1)(D) states that n payment shall be made fr any services that are cnsidered investigatinal r experimental. IOM and Regulatin Citatins CMS Manual System, Publicatin , Medicare Benefit Plicy Manual, Chapter 15, ,addresses requirements fr rdering and fllwing rders fr diagnstic tests. Transmittal 94, Change Request 6100, Dated August 29, 2008, , addresses physician signature requirements fr diagnstic tests. CMS IOM Publicatin ,Medicare Natinal Cverage Determinatins Manual, Chapter 1, Sectins and CMS IOM Publicatin ,Medicare Claims Prcessing Manual, Chapter 23, Sectin 10 Reprting ICD Diagnsis and Prcedure cdes. CMS Manual System, Publicatin ,Medicare Prgram Integrity Manual, Chapter 3, , Diagnsis Cde Requirement. CMS IOM Publicatin ,Medicare Cntractr Beneficiary and Prvider Cmmunicatins Manual, Chapter 5 Crrect Cding Initiative. The Cde f Federal Regulatins (CFR), 42 CFR Specifies that all diagnstic tests must be rdered by the physician wh is treating the beneficiary. 3

4 The Cde f Federal Regulatins (CFR), 42 CFR (k)(1). States any services that are nt reasnable and necessary are excluded frm cverage. Jurisdictin Arizna Super MAC J - F Jurisdictin Cverage Guidance Ntice: It is nt apprpriate t bill Medicare fr services that are nt cvered (as described by this entire LCD) as if they are cvered. When billing fr nn-cvered services, use the apprpriate mdifier. Cmpliance with the prvisins in this plicy may be mnitred and addressed thrugh pst payment data analysis and subsequent medical review audits. Cverage Indicatins, Limitatins and/r Medical Necessity Histry/Backgrund and/r General Infrmatin Nn-invasive vascular diagnstic studies utilize ultrasnic Dppler and physilgic principles t assess irregularities in bld flw in the venus system. Vascular studies include patient care required t perfrm the studies, supervisin f the studies and interpretatin f study results with cpies fr patient recrds f hard cpy utput with analysis f all data, including bidirectinal vascular flw r imaging when prvided. (AMA 2016 CPT bk, page 626). A hard cpy, r a sft cpy cnvertible t a hard cpy, prvides a permanent recrd f the study perfrmed and must be f a quality that meets accepted radilgic standards. A duplex scan (CPT cdes and 93971) cmbines Dppler spectrum analysis and cnventinal ultrasund, t visualize the structure f bld vessels, hw the bld is flwing thrugh the vessels, and whether there is any bstructin in the vessels. A nn-invasive physilgic study implies functinal measurement prcedures including Dppler wavefrm analysis, bld pressure measurements, r plethysmgraphy. Plethysmgraphy implies vlume measurement prcedures including air, impedance, r strain gauge methds. Fr cding guidelines, please refer t 4

5 Lcal Cverage Article A55529 Cding Guidelines: Nn-Invasive Peripheral Venus Studies. Cvered Indicatins 1. Deep Vein Thrmbsis (DVT) Due t the risk f DVT assciated with pulmnary emblism (PE), bjective testing f venus functin is cnsidered reasnable and necessary in patients that are candidates fr anticagulatin r invasive therapeutic prcedures fr any ne f the fllwing: T evaluate clinical signs r symptms suggestive f acute r new nset DVT such as extremity swelling, tenderness, inflammatin r erythema. Investigatin fr DVT as the surce f a suspected r cnfirmed pulmnary emblism. Evaluatin f unexplained extremity edema, especially unilateral r asymmetric, in an individual at risk fr DVT (e.g., immbile, status-pst majr surgical prcedure, indwelling vascular catheter r prsthesis, r pstpartum). Bilateral r symmetric limb edema is mre likely t result frm a systemic disrder (e.g. cngestive heart failure, hypalbuminemia, arthritis) r certain drugs. Therefre, bilateral limb edema is cnsidered reasnable and necessary fr venus studies in individuals at risk fr DVT when there is n therwise plausible cause. Fllw-up fr patients with knwn venus thrmbsis t mnitr fr prgressin, determine curse f treatment r the need t alter treatment based n new symptms. 2. Chrnic Venus Insufficiency 5

6 Chrnic venus insufficiency is impaired venus return which may cause lwer extremity symptms. Objective testing f venus functin is cnsidered reasnable and necessary in patients that are candidates fr anticagulatin r invasive therapeutic prcedures fr any ne f the fllwing: Evaluatin f Pstthrmbtic (Pstphlebitic) Syndrme (PTS) in patients with symptms f PTS (e.g. chrnic leg pain, leg heaviness, leg swelling, leg itching r ulcers n the leg). Evaluatin f suspected valvular incmpetence in patients with symptmatic chrnic venus insufficiency r symptmatic varicse veins (e.g. significant pain r edema f the lwer leg, ulceratin, thickening and disclratin) suspected t be secndary t venus insufficiency in rder t cnfirm this diagnsis prir t treatment. Pst-prcedural assessment f venus ablatin. If a great r small saphenus vein underges ablatin, a duplex scan f the affected side (CPT cde 93971) is cnsidered reasnable and necessary pstperatively within 72 hurs after the prcedure, t assess the result f the surgery and the pssibility f prpagatin f a thrmbus. Nte: Use ICD-10-CM cde Z09 nly t describe a limited venus duplex (CPT cde 93971) perfrmed within 72 hurs f a saphenus vein ablatin prcedure (CPT cdes 36475, 36476, 36478, r 36479). Nte: Additinal cverage infrmatin pertinent t the treatment f varicse veins and ablatin therapy is lcated in LCD L37291, Treatment f Varicse Veins Disease f the Lwer Extremities. 3. Preperative Examinatins Nn-Invasive Peripheral Venus Studies are cnsidered reasnable and necessary fr select preperative examinatins that meet criteria fr cverage as fllws: 6

7 Bypass surgery- Duplex scan f extremity veins including respnses t cmpressin and ther maneuvers; unilateral r limited study (CPT cde 93971) is indicated fr the preperative examinatin f ptential harvest vein grafts t be utilized during bypass surgery. This service is cnsidered reasnable and necessary when the results f the study are needed t lcate suitable graft vessels. The need fr bypass surgery must be determined prir t perfrmance f the test. Hemdialysis access surgery-vessel mapping fr hemdialysis (HCPCS cde G0365) is indicated fr the preperative examinatin f vessels prir t hemdialysis access site surgery in patients with end stage renal disease (ESRD). This service is cnsidered reasnable and necessary when the results f the study are needed t determine apprpriate vessel utilizatin (i.e., when the patient s clinical evaluatin des nt readily lead t the selectin f a vein that is suitable fr creating a dialysis fistula). The need fr a hemdialysis access site must be determined prir t perfrmance f the test. Limitatins 1. Objective testing f peripheral venus functin is cnsidered nt reasnable and necessary and therefre nn- cvered fr any ne f the fllwing: Asymptmatic varicse veins Rutine screening tests Nte: ICD-10-CM diagnsis cde Z13.9 (special screening f ther cnditins, unspecified cnditin) shuld be used t indicate screening tests perfrmed in the absence f a specific sign, symptm, r cmplaint. Use f ICD-10-CM cde Z13.9 will result in the denial f claims as nn-cvered screening services. 7

8 When the evaluatin, management and treatment f the varicse vein are cnsidered t be csmetic nly, billing fr these services will be denied as csmetic. 2. Nn-invasive vascular studies are cnsidered nt reasnable and necessary if the results are nt needed fr clinical decisin making. If the study results will have n impact n the decisin fr further diagnstic r therapeutic prcedures r will nt prvide any unique diagnstic infrmatin that wuld impact patient management, then the nn-invasive studies are nt reasnable and necessary. Fr example, if it is evident frm the findings f the histry and physical examinatin that the patient is ging t prceed t angigraphy, then nn-invasive vascular studies are nt reasnable and necessary. 3. The fllwing limitatins apply t multiple nn-invasive studies n the same encunter r same day: Perfrmance f bth nn-invasive extracranial arterial studies (CPT cdes r 93882) and nn- invasive evaluatin f extremity veins (CPT cdes r 93971) during the same encunter is rarely medically necessary. Dcumentatin must clearly supprt the medical necessity if bth prcedures are perfrmed during the same encunter, and be made available upn request. Because signs and symptms f arterial cclusive disease and venus disease are s divergent, the perfrmance f simultaneus arterial and venus studies during the same encunter is rarely medically necessary. Cnsequently, dcumentatin must clearly supprt the medical necessity f bth prcedures if perfrmed during the same encunter, and be made available upn request. It is rarely medically necessary t perfrm lwer extremity and upper extremity studies n the same day. Dcumentatin must clearly supprt the medical necessity 8

9 f bth upper and lwer extremities if perfrmed n the same day, and be made available upn request. 4. "The use f a simple hand-held r ther Dppler device that des nt prduce hard cpy data r that prduces a recrd that des nt permit analysis f bidirectinal vascular flw, is cnsidered t be part f the physical examinatin f the vascular system and is nt separately reprted. (AMA 2016 CPT Bk, Page 626) Dppler prcedures perfrmed with zer-crssers (i.e., analg [strip chart recrder] analysis) are als included in any ther E/M service. Therefre, it is nt reasnable and necessary t reprt these prcedures as separate services. 5. Accrding t NCD 20.14, the fllwing methds are nt cvered: Mechanical Oscillmetry Inductance Plethysmgraphy Capacitance Plethysmgraphy Phtelectric Plethysmgraphy Training Requirements/Certificatins The accuracy f nn-invasive diagnstic testing studies depends n the knwledge, skill and experience f the physician and/r technlgist perfrming and interpreting the study. Dcumentatin f applicable training and experience must be maintained and made available upn request. Services will be cnsidered reasnable and necessary nly if perfrmed by apprpriately trained persnnel. All nn-invasive vascular studies must be: 9

10 1. Perfrmed by a qualified physician; r 2. Perfrmed under the general supervisin f a qualified physician by a licensed* technlgist wh is certified in vascular technlgy; r 3. Perfrmed in an accredited vascular labratry *State licensure fr a technlgist is required in additin t apprpriate recgnized certificatin. Dcumentatin f current, active licensure must be maintained and made available upn request. In the absence f a state/federal district licensing bard, the requirement fr licensure is waived. A qualified physician fr this service/prcedure is defined as: A. Physician is prperly enrlled in Medicare; and B. Training and expertise must have been acquired within the framewrk f an accredited residency and/r fellwship prgram in the applicable specialty/subspecialty in the United States r must reflect equivalent educatin, training, and expertise endrsed by an academic institutin in the United States and/r by the applicable specialty/subspecialty sciety in the United States. General Supervisin means the prcedure is furnished under the physician's verall directin and cntrl, but the physician's presence is nt required during the perfrmance f the prcedure. Under General Supervisin, the training f the nn-physician persnnel wh actually perfrms the diagnstic prcedure and the maintenance f the necessary equipment and supplies are the cntinuing respnsibility f the physician. Ntice: This LCD impses frequency limitatins as well as diagnsis limitatins that supprt diagnsis t prcedure cde autmated denials. Hwever, services perfrmed fr any given diagnsis must meet all f the indicatins and limitatins stated in this plicy, the general requirements fr medical necessity as stated in CMS payment plicy manuals, any and all existing CMS natinal cverage determinatins, and all Medicare payment rules. 10

11 Fr frequency limitatins please refer t the Utilizatin Guidelines sectin belw. As published in CMS IOM , Chapter 13, Sectin , in rder t be cvered under Medicare, a service shall be reasnable and necessary. When apprpriate, cntractrs shall describe the circumstances under which the prpsed LCD fr the service is cnsidered reasnable and necessary under Sectin 1862(a)(1)(A). Cntractrs shall cnsider a service t be reasnable and necessary if the cntractr determines that the service is: Safe and effective. Nt experimental r investigatinal (exceptin: rutine csts f qualifying clinical trial services with dates f service n r after September 19, 2000 that meet the requirements f the Clinical Trials NCD are cnsidered reasnable and necessary). Apprpriate, including the duratin and frequency that is cnsidered apprpriate fr the service, in terms f whether it is: Furnished in accrdance with accepted standards f medical practice fr the diagnsis r treatment f the patient's cnditin r t imprve the functin f a malfrmed bdy member. Furnished in a setting apprpriate t the patient's medical needs and cnditin. Ordered and furnished by qualified persnnel. 11

12 One that meets, but des nt exceed, the patient's medical needs. At least as beneficial as an existing and available medically apprpriate alternative. The redeterminatin prcess may be utilized fr cnsideratin f services perfrmed utside f the reasnable and necessary requirements in this LCD. Prpsed Prcess Infrmatin Synpsis f Changes Assciated Infrmatin Fields Changes Changed Nt Applicable Dcumentatin Requirements 1. All dcumentatin must be maintained in the patient s medical recrd and made available t the cntractr upn request. 12

13 2. Every page f the recrd must be legible and include apprpriate patient identificatin infrmatin (e.g., cmplete name, dates f service(s)). The dcumentatin must include the legible signature f the physician r nn-physician practitiner respnsible fr and prviding the care t the patient. 3. The submitted medical recrd shuld supprt the use f the selected ICD-10-CM cde(s). The submitted CPT/HCPCS cde shuld describe the service perfrmed. 4. The medical recrd dcumentatin must supprt the medical necessity f the services as directed in this plicy. 5. The medical necessity fr perfrming bth nn-invasive extracranial arterial studies (CPT cdes r 93882) and nn-invasive evaluatin f extremity veins (CPT cdes r 93971) during the same encunter must be clearly dcumented in the medical recrd. 6. The medical necessity fr perfrming simultaneus arterial and venus studies during the same encunter must be clearly dcumented in the medical recrd. 7. The medical necessity f perfrming lwer extremity and upper extremity studies n the same day must be clearly dcumented in the medical recrd. Utilizatin Guidelines In accrdance with CMS Ruling 95-1 (V), utilizatin f these services shuld be cnsistent with lcally acceptable standards f practice. Only ne preperative scan (CPT cde 93971) is cnsidered reasnable and necessary fr bypass surgery. 13

14 Only ne preperative scan (HCPCS cde G0365) is cnsidered reasnable and necessary per hemdialysis access site surgery. Only ne limited study (CPT cde 93971) is cnsidered reasnable and necessary pst peratively within 72 hurs f a saphenus vein ablatin, whether surgery is perfrmed n ne side r bilaterally. One Dppler ultrasund study r duplex scan will be cvered fr dcumentatin f disease and mapping fr chrnic venus insufficiency r symptmatic varicse veins. Ntice: This LCD impses utilizatin guideline limitatins. Despite Medicare allwing up t these maximums, each patient s cnditin and respnse t treatment must medically warrant the number f services reprted fr payment. Medicare requires the medical necessity fr each service reprted t be clearly demnstrated in the patient s medical recrd. Medicare expects that patients will nt rutinely require the maximum allwable number f services. 1. ACR-AIUM-SPR-SRU Practice Parameter fr the Perfrmance f Peripheral Venus Ultrasund Examinatin. American Cllege f Radilgy. Revised 2015 (Reslutin 33). Surces f Infrmatin and Basis fr Decisin 2. Duketis JD. Chrnic Venus Insufficiency and Pstphlebitic Syndrme. Merck Manual prfessinal versin nline last revised May 2014: disrders/chrnic-venus-insufficiencyand-pstphlebitic-syndrme. 3. Eskandari MK, Pearce WH, Ya J. Current Vascular Surgery Sheltn, CT: Peple s Medical Publishing Huse USA, Accessed nline n August 18,

15 4. Harlander-Lcke M, Jimenez JC, Lawrence PF, et al. Management f endvenus heat-induced thrmbus using a classificatin system and treatment algrithm fllwing segmental thermal ablatin f the small saphenus vein. Jurnal f Vascular Surgery, August 2013;58(2): Khilnani NM, Grassi CJ, Kundu S, et al. Multi-sciety Cnsensus Quality Imprvement Guidelines fr the Treatment f Lwer-extremity Superficial Venus Insufficiency with Endvenus Thermal Ablatin frm the Sciety f Interventinal Radilgy, Cardivascular Interventinal Radilgical Sciety f Eurpe, American Cllege f Pheblgy, and Canadian Interventinal Radilgy Assciatin. J Vasc Interv Radil 2010;21: Lawrence, Peter F et al, Classificatin f prximal endvenus clsure levels and treatment algrithm. Jurnal f Vascular Surgery. August 2010, Vl 52 (2): Luckraz H, Lwe J, Pugh N, et al. Pre-perative lng saphenus vein mapping predicts vein anatmy and quality leading t imprved pstperative leg mrbidity. Interactive Cardivascular and Thracic Surgery ; Office f Inspectr General DHHS, Medicare Part B Billing fr Vascular Ultrasund. OEI July Stanley, D. (2004). The imprtance f Interscietal Cmmissin fr the accreditatin f vascular labratries (ICAVL) certificatin fr nninvasive peripheral vascular tests: The Tennessee experience. The Jurnal fr Vascular Ultrasund, 28(2),

16 10. Vazquez, SR, Kahn, SR. Pstthrmbtic Syndrme. Circulatin. 2010;121:e217-e Grnik HL, Gerhard-Herman MD, Misra S, Mhler ER III, Zierler RE. ACCF/ACR/AIUM/ASE/ASN/IAC/SCAI/SCCT/SIR/SVM/SVS 2013 apprpriate use criteria fr peripheral vascular ultrasund and physilgical testing part II: testing fr venus disease and evaluatin f hemdialysis access: a reprt f the American Cllege f Cardilgy Fundatin Apprpriate Use Criteria Task Frce, the American Cllege f Radilgy, American Institute f Ultrasund in Medicine, American Sciety f Echcardigraphy, American Sciety f Nephrlgy, Interscietal Accreditatin Cmmissin, Sciety fr Cardivascular Angigraphy and Interventins, Sciety f Cardivascular Cmputed Tmgraphy, Sciety f Interventinal Radilgy, Sciety fr Vascular Medicine, Sciety fr Vascular Medicine, Sciety fr Vascular Surgery. J Am Cll Cardil 2013;62: Other Cntractr Plicies L35451, Nn-Invasive Peripheral Venus Studies, Nvitas Slutins Jurisdictins H and L Lcal Cverage Determinatin L33693, Nn-Invasive Evaluatin f Extremity Veins, First Cast Service Optins Jurisdictin N Lcal Cverage Determinatin L34229, Nninvasive Peripheral Venus Studies, Nridian Healthcare Slutins Jurisdictin E Lcal Cverage Determinatin L33627, Nn-Invasive Vascular Studies, Natinal Gvernment Services Jurisdictin K Lcal Cverage Determinatin 16

17 Open Meetings Part B MAC Cntractr Advisry Cmmittee (CAC) Meetings Cmment Perid Start Date Cmment Perid End Date Released t Final LCD Date Reasn(s) fr Prpsed LCD Prpsed LCD Cntact Meeting Date 06/01/2017 Meeting Infrmatin Nridian Healthcare Slutins Rm W nd Street S Farg, ND State Alaska, Arizna, Idah, Mntana, Nrth Dakta, Oregn, Suth Dakta, Utah, Washingtn, Wyming Meeting Date Meeting Infrmatin State 06/29/2017 Anchrage Alaska 06/20/2017 Phenix Arizna 06/21/2017 Bise Idah 06/14/2017 Telecnference and in persn Cheyenne Mntana, Wyming 06/07/2017 Farg Nrth Dakta 06/24/2017 Prtland Oregn 06/08/2017 Siux Falls Suth Dakta 06/22/2017 Salt Lake City Utah 06/20/2017 Rentn Washingtn 06/01/ /14/2017 Cding Infrmatin Nt yet released. Creatin f Unifrm LCDs Within a MAC Jurisdictin Nridian Healthcare Slutins, LLC JF Part B Cntractr Medical Directr(s) Attentin: Draft LCD Cmments PO Bx 6781 Farg, Nrth Dakta plicydraft@nridian.cm 17

18 Bill Type Cdes Revenue Cdes CPT/HCPCS Cdes 011x Hspital Inpatient (Including Medicare Part A) 012x Hspital Inpatient (Medicare Part B nly) 013x Hspital Outpatient 018x Hspital - Swing Beds 021x Skilled Nursing - Inpatient (Including Medicare Part A) 022x Skilled Nursing - Inpatient (Medicare Part B nly) 023x Skilled Nursing - Outpatient 028x Skilled Nursing - Swing Beds 083x Ambulatry Surgery Center 085x Critical Access Hspital Cntractrs may specify Revenue Cdes t help prviders identify thse Revenue Cdes typically used t reprt this service. In mst instances Revenue Cdes are purely advisry. Unless specified in the plicy, services reprted under ther Revenue Cdes are equally subject t this cverage determinatin. Cmplete absence f all Revenue Cdes indicates that cverage is nt influenced by Revenue Cde and the plicy shuld be assumed t apply equally t all Revenue Cdes. Nte: The cntractr has identified the Bill Type and Revenue Cdes applicable fr use with the CPT/HCPCS cdes included in this LCD. Prviders are reminded that nt all CPT/HCPCS cdes listed can be billed with all Bill Type and/r Revenue Cdes listed. CPT/HCPCS cdes are required t be billed with specific Bill Type and Revenue Cdes. Prviders are encuraged t refer t the CMS Internet-Only Manual (IOM) Pub , Medicare Claims Prcessing Manual, fr further guidance Other Diagnstic Services - Peripheral Vascular Lab Grup 1: Paragraph Prviders are reminded t refer t the lng descriptrs f the CPT cdes in their CPT bk. Grup 1: Cdes DUPLEX SCAN OF EXTREMITY VEINS INCLUDING RESPONSES TO COMPRESSION AND OTHER MANEUVERS; COMPLETE BILATERAL STUDY DUPLEX SCAN OF EXTREMITY VEINS INCLUDING RESPONSES TO COMPRESSION AND OTHER MANEUVERS; UNILATERAL OR LIMITED STUDY 18

19 Grup 2: Paragraph N/A Grup 2: Cdes VESSEL MAPPING OF VESSELS FOR HEMODIALYSIS ACCESS (SERVICES FOR PREOPERATIVE VESSEL MAPPING PRIOR TO G0365 CREATION OF HEMODIALYSIS ACCESS USING AN AUTOGENOUS HEMODIALYSIS CONDUIT, INCLUDING ARTERIAL INFLOW AND VENOUS OUTFLOW) Des the CPT 30% Cding Rule N Apply? Grup 1: Paragraph It is the prvider s respnsibility t select cdes carried ut t the highest level f specificity and selected frm the ICD-10-CM cde bk apprpriate t the year in which the service is rendered fr the claim(s) submitted. Medicare is establishing the fllwing limited cverage fr CPT/HCPCS cdes and 93971: Cvered fr: Grup 1: Cdes I26.01 Septic pulmnary emblism with acute cr pulmnale Saddle emblus f pulmnary artery with acute cr I26.02 pulmnale ICD-10 Cdes that Supprt Medical Necessity Nte: Perfrmance is ptimized by using cde ranges. I26.09 Other pulmnary emblism with acute cr pulmnale I26.90 Septic pulmnary emblism withut acute cr pulmnale I26.92 Saddle emblus f pulmnary artery withut acute cr pulmnale I26.99 Other pulmnary emblism withut acute cr pulmnale I74.9* Emblism and thrmbsis f unspecified artery I80.01 Phlebitis and thrmbphlebitis f superficial vessels f right lwer extremity I80.02 Phlebitis and thrmbphlebitis f superficial vessels f left lwer extremity I80.03 Phlebitis and thrmbphlebitis f superficial vessels f lwer extremities, bilateral I80.11 Phlebitis and thrmbphlebitis f right femral vein I80.12 Phlebitis and thrmbphlebitis f left femral vein I80.13 Phlebitis and thrmbphlebitis f femral vein, bilateral I Phlebitis and thrmbphlebitis f right iliac vein I Phlebitis and thrmbphlebitis f left iliac vein 19

20 I Phlebitis and thrmbphlebitis f iliac vein, bilateral I Phlebitis and thrmbphlebitis f right ppliteal vein I Phlebitis and thrmbphlebitis f left ppliteal vein I Phlebitis and thrmbphlebitis f ppliteal vein, bilateral I Phlebitis and thrmbphlebitis f right tibial vein I Phlebitis and thrmbphlebitis f left tibial vein I Phlebitis and thrmbphlebitis f tibial vein, bilateral I Phlebitis and thrmbphlebitis f ther deep vessels f right lwer extremity I Phlebitis and thrmbphlebitis f ther deep vessels f left lwer extremity I Phlebitis and thrmbphlebitis f ther deep vessels f lwer extremity, bilateral I80.8 Phlebitis and thrmbphlebitis f ther sites I82.1 Thrmbphlebitis migrans I Acute emblism and thrmbsis f inferir vena cava I Acute emblism and thrmbsis f right femral vein I Acute emblism and thrmbsis f left femral vein I Acute emblism and thrmbsis f femral vein, bilateral I Acute emblism and thrmbsis f right iliac vein I Acute emblism and thrmbsis f left iliac vein I Acute emblism and thrmbsis f iliac vein, bilateral I Acute emblism and thrmbsis f right ppliteal vein I Acute emblism and thrmbsis f left ppliteal vein I Acute emblism and thrmbsis f ppliteal vein, bilateral I Acute emblism and thrmbsis f right tibial vein I Acute emblism and thrmbsis f left tibial vein I Acute emblism and thrmbsis f tibial vein, bilateral I Acute emblism and thrmbsis f ther specified deep vein f right lwer extremity I Acute emblism and thrmbsis f ther specified deep vein f left lwer extremity I Acute emblism and thrmbsis f ther specified deep vein f lwer extremity, bilateral I Chrnic emblism and thrmbsis f right femral vein I Chrnic emblism and thrmbsis f left femral vein I Chrnic emblism and thrmbsis f femral vein, bilateral I Chrnic emblism and thrmbsis f right iliac vein 20

21 I Chrnic emblism and thrmbsis f left iliac vein I Chrnic emblism and thrmbsis f iliac vein, bilateral I Chrnic emblism and thrmbsis f right ppliteal vein I Chrnic emblism and thrmbsis f left ppliteal vein I Chrnic emblism and thrmbsis f ppliteal vein, bilateral I Chrnic emblism and thrmbsis f right tibial vein I Chrnic emblism and thrmbsis f left tibial vein I Chrnic emblism and thrmbsis f tibial vein, bilateral I Chrnic emblism and thrmbsis f ther specified deep vein f right lwer extremity I Chrnic emblism and thrmbsis f ther specified deep vein f left lwer extremity I Chrnic emblism and thrmbsis f ther specified deep vein f lwer extremity, bilateral I Acute emblism and thrmbsis f superficial veins f right upper extremity I Acute emblism and thrmbsis f superficial veins f left upper extremity I Acute emblism and thrmbsis f superficial veins f upper extremity, bilateral I Acute emblism and thrmbsis f deep veins f right upper extremity I Acute emblism and thrmbsis f deep veins f left upper extremity I Acute emblism and thrmbsis f deep veins f upper extremity, bilateral I Chrnic emblism and thrmbsis f superficial veins f right upper extremity I Chrnic emblism and thrmbsis f superficial veins f left upper extremity I Chrnic emblism and thrmbsis f superficial veins f upper extremity, bilateral I Chrnic emblism and thrmbsis f deep veins f right upper extremity I Chrnic emblism and thrmbsis f deep veins f left upper extremity I Chrnic emblism and thrmbsis f deep veins f upper extremity, bilateral I82.A11 Acute emblism and thrmbsis f right axillary vein I82.A12 Acute emblism and thrmbsis f left axillary vein 21

22 I82.A13 I82.A21 I82.A22 I82.A23 I82.C11 I82.C12 I82.C13 I82.C21 I82.C22 I82.C23 I I I Acute emblism and thrmbsis f axillary vein, bilateral Chrnic emblism and thrmbsis f right axillary vein Chrnic emblism and thrmbsis f left axillary vein Chrnic emblism and thrmbsis f axillary vein, bilateral Acute emblism and thrmbsis f right internal jugular vein Acute emblism and thrmbsis f left internal jugular vein Acute emblism and thrmbsis f internal jugular vein, bilateral Chrnic emblism and thrmbsis f right internal jugular vein Chrnic emblism and thrmbsis f left internal jugular vein Chrnic emblism and thrmbsis f internal jugular vein, bilateral Emblism and thrmbsis f superficial veins f right lwer extremities Emblism and thrmbsis f superficial veins f left lwer extremities Emblism and thrmbsis f superficial veins f lwer extremities, bilateral I Acute emblism and thrmbsis f ther specified veins I Chrnic emblism and thrmbsis f ther specified veins I Varicse veins f right lwer extremity with ulcer f thigh I Varicse veins f right lwer extremity with ulcer f calf I Varicse veins f right lwer extremity with ulcer f ankle I Varicse veins f right lwer extremity with ulcer f heel and midft I Varicse veins f right lwer extremity with ulcer ther part f ft I Varicse veins f right lwer extremity with ulcer ther part f lwer leg I Varicse veins f left lwer extremity with ulcer f thigh I Varicse veins f left lwer extremity with ulcer f calf I Varicse veins f left lwer extremity with ulcer f ankle I Varicse veins f left lwer extremity with ulcer f heel and midft I Varicse veins f left lwer extremity with ulcer ther part f ft 22

23 I Varicse veins f left lwer extremity with ulcer ther part f lwer leg I83.11 Varicse veins f right lwer extremity with inflammatin I83.12 Varicse veins f left lwer extremity with inflammatin I Varicse veins f right lwer extremity with bth ulcer f thigh and inflammatin I Varicse veins f right lwer extremity with bth ulcer f calf and inflammatin I Varicse veins f right lwer extremity with bth ulcer f ankle and inflammatin I Varicse veins f right lwer extremity with bth ulcer f heel and midft and inflammatin I Varicse veins f right lwer extremity with bth ulcer ther part f ft and inflammatin I Varicse veins f right lwer extremity with bth ulcer f ther part f lwer extremity and inflammatin I Varicse veins f left lwer extremity with bth ulcer f thigh and inflammatin I Varicse veins f left lwer extremity with bth ulcer f calf and inflammatin I Varicse veins f left lwer extremity with bth ulcer f ankle and inflammatin I Varicse veins f left lwer extremity with bth ulcer f heel and midft and inflammatin I Varicse veins f left lwer extremity with bth ulcer ther part f ft and inflammatin I Varicse veins f left lwer extremity with bth ulcer f ther part f lwer extremity and inflammatin I Varicse veins f right lwer extremities with pain I Varicse veins f left lwer extremities with pain I Varicse veins f bilateral lwer extremities with pain I Varicse veins f right lwer extremities with ther cmplicatins I Varicse veins f left lwer extremities with ther cmplicatins I Varicse veins f bilateral lwer extremities with ther cmplicatins I Pstthrmbtic syndrme withut cmplicatins f right lwer extremity I Pstthrmbtic syndrme withut cmplicatins f left lwer extremity 23

24 I Pstthrmbtic syndrme withut cmplicatins f bilateral lwer extremity I Pstthrmbtic syndrme with ulcer f right lwer extremity I Pstthrmbtic syndrme with ulcer f left lwer extremity I Pstthrmbtic syndrme with ulcer f bilateral lwer extremity I Pstthrmbtic syndrme with inflammatin f right lwer extremity I Pstthrmbtic syndrme with inflammatin f left lwer extremity I Pstthrmbtic syndrme with inflammatin f bilateral lwer extremity I Pstthrmbtic syndrme with ulcer and inflammatin f right lwer extremity I Pstthrmbtic syndrme with ulcer and inflammatin f left lwer extremity I Pstthrmbtic syndrme with ulcer and inflammatin f bilateral lwer extremity I Pstthrmbtic syndrme with ther cmplicatins f right lwer extremity I Pstthrmbtic syndrme with ther cmplicatins f left lwer extremity I Pstthrmbtic syndrme with ther cmplicatins f bilateral lwer extremity I87.1 Cmpressin f vein I87.2 Venus insufficiency (chrnic) (peripheral) I Chrnic venus hypertensin (idipathic) with ulcer f right lwer extremity I Chrnic venus hypertensin (idipathic) with ulcer f left lwer extremity I Chrnic venus hypertensin (idipathic) with ulcer f bilateral lwer extremity I Chrnic venus hypertensin (idipathic) with inflammatin f right lwer extremity I Chrnic venus hypertensin (idipathic) with inflammatin f left lwer extremity I Chrnic venus hypertensin (idipathic) with inflammatin f bilateral lwer extremity 24

25 I Chrnic venus hypertensin (idipathic) with ulcer and inflammatin f right lwer extremity I Chrnic venus hypertensin (idipathic) with ulcer and inflammatin f left lwer extremity I Chrnic venus hypertensin (idipathic) with ulcer and inflammatin f bilateral lwer extremity I Chrnic venus hypertensin (idipathic) with ther cmplicatins f right lwer extremity I Chrnic venus hypertensin (idipathic) with ther cmplicatins f left lwer extremity I Chrnic venus hypertensin (idipathic) with ther cmplicatins f bilateral lwer extremity I96 Gangrene, nt elsewhere classified J80 Acute respiratry distress syndrme J96.00 Acute respiratry failure, unspecified whether with hypxia r hypercapnia J96.01 Acute respiratry failure with hypxia J96.02 Acute respiratry failure with hypercapnia J96.90 Respiratry failure, unspecified, unspecified whether with hypxia r hypercapnia L Nn-pressure chrnic ulcer f right thigh limited t breakdwn f skin L Nn-pressure chrnic ulcer f right thigh with fat layer expsed L Nn-pressure chrnic ulcer f right thigh with necrsis f muscle L Nn-pressure chrnic ulcer f right thigh with necrsis f bne L Nn-pressure chrnic ulcer f left thigh limited t breakdwn f skin L Nn-pressure chrnic ulcer f left thigh with fat layer expsed L Nn-pressure chrnic ulcer f left thigh with necrsis f muscle L Nn-pressure chrnic ulcer f left thigh with necrsis f bne L Nn-pressure chrnic ulcer f left thigh with unspecified severity L Nn-pressure chrnic ulcer f right calf limited t breakdwn f skin 25

26 L L L L L L L L L L L L L L L L L L L L L Nn-pressure chrnic ulcer f right calf with fat layer expsed Nn-pressure chrnic ulcer f right calf with necrsis f muscle Nn-pressure chrnic ulcer f right calf with necrsis f bne Nn-pressure chrnic ulcer f right calf with unspecified severity Nn-pressure chrnic ulcer f left calf limited t breakdwn f skin Nn-pressure chrnic ulcer f left calf with fat layer expsed Nn-pressure chrnic ulcer f left calf with necrsis f muscle Nn-pressure chrnic ulcer f left calf with necrsis f bne Nn-pressure chrnic ulcer f left calf with unspecified severity Nn-pressure chrnic ulcer f right ankle limited t breakdwn f skin Nn-pressure chrnic ulcer f right ankle with fat layer expsed Nn-pressure chrnic ulcer f right ankle with necrsis f muscle Nn-pressure chrnic ulcer f right ankle with necrsis f bne Nn-pressure chrnic ulcer f right ankle with unspecified severity Nn-pressure chrnic ulcer f left ankle limited t breakdwn f skin Nn-pressure chrnic ulcer f left ankle with fat layer expsed Nn-pressure chrnic ulcer f left ankle with necrsis f muscle Nn-pressure chrnic ulcer f left ankle with necrsis f bne Nn-pressure chrnic ulcer f left ankle with unspecified severity Nn-pressure chrnic ulcer f right heel and midft limited t breakdwn f skin Nn-pressure chrnic ulcer f right heel and midft with fat layer expsed 26

27 L L L L L L L L L L L L L L L L L L L L L Nn-pressure chrnic ulcer f right heel and midft with necrsis f muscle Nn-pressure chrnic ulcer f right heel and midft with necrsis f bne Nn-pressure chrnic ulcer f right heel and midft with unspecified severity Nn-pressure chrnic ulcer f left heel and midft limited t breakdwn f skin Nn-pressure chrnic ulcer f left heel and midft with fat layer expsed Nn-pressure chrnic ulcer f left heel and midft with necrsis f muscle Nn-pressure chrnic ulcer f left heel and midft with necrsis f bne Nn-pressure chrnic ulcer f left heel and midft with unspecified severity Nn-pressure chrnic ulcer f ther part f right ft limited t breakdwn f skin Nn-pressure chrnic ulcer f ther part f right ft with fat layer expsed Nn-pressure chrnic ulcer f ther part f right ft with necrsis f muscle Nn-pressure chrnic ulcer f ther part f right ft with necrsis f bne Nn-pressure chrnic ulcer f ther part f right ft with unspecified severity Nn-pressure chrnic ulcer f ther part f left ft limited t breakdwn f skin Nn-pressure chrnic ulcer f ther part f left ft with fat layer expsed Nn-pressure chrnic ulcer f ther part f left ft with necrsis f muscle Nn-pressure chrnic ulcer f ther part f left ft with necrsis f bne Nn-pressure chrnic ulcer f ther part f left ft with unspecified severity Nn-pressure chrnic ulcer f ther part f right lwer leg limited t breakdwn f skin Nn-pressure chrnic ulcer f ther part f right lwer leg with fat layer expsed Nn-pressure chrnic ulcer f ther part f right lwer leg with necrsis f muscle 27

28 L Nn-pressure chrnic ulcer f ther part f right lwer leg with necrsis f bne L Nn-pressure chrnic ulcer f ther part f right lwer leg with unspecified severity L Nn-pressure chrnic ulcer f ther part f left lwer leg limited t breakdwn f skin L Nn-pressure chrnic ulcer f ther part f left lwer leg with fat layer expsed L Nn-pressure chrnic ulcer f ther part f left lwer leg with necrsis f muscle L Nn-pressure chrnic ulcer f ther part f left lwer leg with necrsis f bne L Nn-pressure chrnic ulcer f ther part f left lwer leg with unspecified severity M71.21 Synvial cyst f ppliteal space [Baker], right knee M71.22 Synvial cyst f ppliteal space [Baker], left knee M Pain in right arm M Pain in left arm M Pain in right leg M Pain in left leg M Pain in right upper arm M Pain in left upper arm M Pain in right frearm M Pain in left frearm M Pain in right hand M Pain in left hand M Pain in right finger(s) M Pain in left finger(s) M Pain in right thigh M Pain in left thigh M Pain in right lwer leg M Pain in left lwer leg M Pain in right ft M Pain in left ft M Pain in right te(s) M Pain in left te(s) O22.21 Superficial thrmbphlebitis in pregnancy, first trimester O22.22 Superficial thrmbphlebitis in pregnancy, secnd trimester 28

29 O22.23 Superficial thrmbphlebitis in pregnancy, third trimester O22.31 Deep phlebthrmbsis in pregnancy, first trimester O22.32 Deep phlebthrmbsis in pregnancy, secnd trimester O22.33 Deep phlebthrmbsis in pregnancy, third trimester O87.0 Superficial thrmbphlebitis in the puerperium O87.1 Deep phlebthrmbsis in the puerperium O Thrmbemblism in pregnancy, first trimester O Thrmbemblism in pregnancy, secnd trimester O Thrmbemblism in pregnancy, third trimester O88.22 Thrmbemblism in childbirth O88.23 Thrmbemblism in the puerperium Q27.31 Arterivenus malfrmatin f vessel f upper limb Q27.32 Arterivenus malfrmatin f vessel f lwer limb Q27.8 Other specified cngenital malfrmatins f peripheral vascular system R04.2 Hemptysis R06.00 Dyspnea, unspecified R06.02 Shrtness f breath R06.09 Other frms f dyspnea R06.82 Tachypnea, nt elsewhere classified R07.1 Chest pain n breathing R07.81 Pleurdynia R07.82 Intercstal pain R07.89 Other chest pain R07.9 Chest pain, unspecified R22.31 Lcalized swelling, mass and lump, right upper limb R22.32 Lcalized swelling, mass and lump, left upper limb R22.33 Lcalized swelling, mass and lump, upper limb, bilateral R22.41 Lcalized swelling, mass and lump, right lwer limb R22.42 Lcalized swelling, mass and lump, left lwer limb R22.43 Lcalized swelling, mass and lump, lwer limb, bilateral R60.0 Lcalized edema R60.1 Generalized edema R60.9 Edema, unspecified T80.0XXA Air emblism fllwing infusin, transfusin and therapeutic injectin, initial encunter T80.1XXA Vascular cmplicatins fllwing infusin, transfusin and therapeutic injectin, initial encunter 29

30 ICD-10 Cdes that DO NOT Supprt Medical Necessity Nte: Perfrmance T81.72XA Cmplicatin f vein fllwing a prcedure, nt elsewhere classified, initial encunter Z01.810* Encunter fr preprcedural cardivascular examinatin Z01.818* Encunter fr ther preprcedural examinatin Z09* Encunter fr fllw-up examinatin after cmpleted treatment fr cnditins ther than malignant neplasm Grup 1: Asterisk *NOTE: Use ICD-10-CM cde I74.9 t reprt paradxical emblism. *NOTE: ICD-10-CM cde Z is nly cvered fr CPT cde *NOTE: ICD-10-CM cde Z is cvered fr either CPT/HCPCS cde r G0365 nly (Refer t Grup 2 cdes fr HCPCS cde G0365). Please refer t Article A55529, Cding Guidelines: Nn-Invasive Peripheral Venus Studies, fr mre infrmatin n reprting these cdes. *NOTE: Use ICD-10-CM cde Z09 nly t describe a limited venus duplex (CPT cde 93971) perfrmed within 72 hurs f a saphenus vein ablatin prcedure (CPT cdes 36475, 36476, 36478, r 36479). Grup 2: Paragraph Medicare is establishing the fllwing limited cverage fr HCPCS cde G0365: Cvered fr: Grup 2: Cdes N18.4 Chrnic kidney disease, stage 4 (severe) N18.5 Chrnic kidney disease, stage 5 N18.6 End stage renal disease Z01.818* Encunter fr ther preprcedural examinatin Grup 2: Asterisk *NOTE: HCPCS cde G0365 reprted with ICD-10-CM cde Z requires a secndary diagnsis cde f N18.4, N18.5, r N18.6. ICD-10- CM cde Z is cvered fr either CPT/HCPCS cde r G0365 nly (Refer t Grup 1 cdes fr CPT cde 93971). Please refer t Article A55529, Cding Guidelines: Nn-Invasive Peripheral Venus Studies, fr mre infrmatin n reprting these cdes. Grup 1: Paragraph All thse nt listed under the ICD-10 Cdes that Supprt Medical Necessity sectin f this plicy. Grup 1: Cdes 30

31 is ptimized by using cde ranges. Additinal ICD-10 Infrmatin Assciated Dcuments Attachments Related Lcal Cverage Dcuments Related Natinal Cverage Dcuments There are n attachments fr this LCD. This LCD versin has n Related Lcal Cverage Dcuments. This LCD versin has n Related Natinal Cverage Dcuments. 31

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

Solid Organ Transplant Benefits to Change for Texas Medicaid

Solid Organ Transplant Benefits to Change for Texas Medicaid Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS) Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember

More information

Indications and Limitations of Coverage and/or Medical back to top

Indications and Limitations of Coverage and/or Medical back to top Fr services perfrmed n r after 09/15/2009 Original Determinatin Ending Date Revisin Effective Date Revisin Ending Date Indicatins and Limitatins f Cverage and/r Medical Necessity Indicatins Medicare cverage

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health

More information

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram

More information

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient Image Surce: https://s-media-cache-ak0.pinimg.cm/736x/7c/29/91/7c2991805f004e1ca05e42a79883f4a7.jpg 6/30/2017 Curse Objectives A Practical Guide t Cding fr Audilgists in 2017 Megan Keirans, AuD University

More information

TEXAS-MAC - PART B-TRAILBLAZER TABLE OF CONTENTS

TEXAS-MAC - PART B-TRAILBLAZER TABLE OF CONTENTS TABLE OF CONTENTS CPT t LCD ID... 4 L26500- Autmatic Implantable Cardiac Defibrillatr (AICD) - 4C-58AB... 14 L26529- Cardiac Catheterizatin - 4C-50AB... 23 L26534- Transthracic Echcardigraphy (TTE) - 4C-52AB...

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Non-Invasive Peripheral Venous Studies (L35451) MP-067-MC-PA Medical Management Provider Notice Date: 05/01/2018 Issue Date:

More information

Fee Schedule - Home Health Care- 2015

Fee Schedule - Home Health Care- 2015 Fee Schedule - Hme Health Care- 2015 01/01/2015 1600 E Century Ave Ste 1 PO Bx 5585 Bismarck ND 58506-5585 www.wrkfrcesafety.cm Cpyright Ntice The five character cdes included in the Nrth Dakta Fee Schedule

More information

Guidelines, Policies and Statements D19 Statement on Visceral Vascular Testing Using Ultrasound

Guidelines, Policies and Statements D19 Statement on Visceral Vascular Testing Using Ultrasound Guidelines, Plicies and Statements D19 Statement n Visceral Vascular Testing Using Ultrasund Disclaimer and Cpyright The ASUM Standards f Practice Bard have made every effrt t ensure that this Guideline/Plicy/Statement

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS INTRODUCTION This ntice prvides an verview f the parental special educatin rights, smetimes called prcedural safeguards

More information

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018 Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered

More information

UNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.

UNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES. Initial privileges (initial appintment) Renewal f privileges (reappintment) Expansin f privileges (mdificatin) INSTRUCTIONS All new applicants must meet the fllwing requirements as apprved by the UNM SRMC

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

Assessment criteria for Primary Health Disciplines Eligibility for Recognition as Credentialled Diabetes Educator. December 2015 ADEA

Assessment criteria for Primary Health Disciplines Eligibility for Recognition as Credentialled Diabetes Educator. December 2015 ADEA Assessment criteria fr Primary Health Disciplines Eligibility fr Recgnitin as Credentialled Diabetes Educatr December 2015 ADEA ASSESSMENT CRITERIA FOR PRIMARY HEALTH DICIPLINES ELIGIBILITY FOR RECOGNITION

More information

QUALITY AND SAFETY MEASURES UPDATE January 2016

QUALITY AND SAFETY MEASURES UPDATE January 2016 CLINICAL EFFECTIVENESS/SAFETY M CORE MEASURES 2015 See attached Results QUALITY AND SAFETY MEASURES UPDATE January 2016 Jint Cmmissin and CMS Cre Measure Dashbard updated with mst recent data available:

More information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in

More information

Coding. Training Guide

Coding. Training Guide Cding (Specialty Hspital) Visin 4.3 (January 2013) Training Guide SurceMedical VisinSH Cding Learning Center f Excellence Last change made: January 2013 2013 Surce Medical Slutins, Inc. All Rights Reserved.

More information

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10 Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

COVERAGE ELIGIBILITY OF SERVICES ASSOCIATED WITH A CANCER CLINICAL TRIAL

COVERAGE ELIGIBILITY OF SERVICES ASSOCIATED WITH A CANCER CLINICAL TRIAL TRIAL Nn-Discriminatin Statement and Multi-Language Interpreter Services infrmatin are lcated at the end f this dcument. Cverage fr services, prcedures, medical devices and drugs are dependent upn benefit

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...

More information

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care. Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,

More information

MEDICARE COVERAGE SUMMARY: TRANSCRANIAL MAGNETIC STIMULATION

MEDICARE COVERAGE SUMMARY: TRANSCRANIAL MAGNETIC STIMULATION OPTUM MEDICARE COVERAGE SUMMARY: TRANSCRANIAL MAGNETIC STIMULATION MEDICARE COVERAGE SUMMARY: TRANSCRANIAL MAGNETIC STIMULATION Guideline Number: Effective Date: April, 2018 INSTRUCTIONS FOR USE This guideline

More information

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF 0055): Diabetes: Eye Exam Measure Steward: NCQA Web Interface

More information

Emergency Department Performance Measures

Emergency Department Performance Measures Emergency Department Perfrmance Measures ACEP Clinical Emergency Data Registry () ACEP Campaign Centers fr Medicare and Medicaid Services (CMS) Medicare Beneficiary Quality Imprvement Prject (MBQIP) ED

More information

Hospital Preparedness Checklist

Hospital Preparedness Checklist Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF Measure Steward: NCQA CMS Web Interface V2.1 Page 1 f 26

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

Weight Assessment and Counseling for Children and Adolescents (NQF 0024)

Weight Assessment and Counseling for Children and Adolescents (NQF 0024) Weight Assessment and Cunseling fr Children and Adlescents (NQF 0024) EMeasure Name Weight Assessment and EMeasure Id Pending Cunseling fr Children and Adlescents Versin Number 1 Set Id Pending Available

More information

ACRIN 6666 Screening Breast US Follow-up Assessment Form

ACRIN 6666 Screening Breast US Follow-up Assessment Form Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

Methadone Maintenance Treatment for Opioid Dependence

Methadone Maintenance Treatment for Opioid Dependence POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin

More information

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Transmittal 86 Date: July 3, SUBJECT: Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)

Transmittal 86 Date: July 3, SUBJECT: Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) CMS Manual System Pub 100-03 Medicare Natinal Cverage Determinatins Department f Health & Human Services (DHHS) Centers fr Medicare & Medicaid Services (CMS) Transmittal 86 Date: July 3, 2008 Change Request

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics Independent Charitable Patient Assistance Prgram (IPAP) Cde f Ethics Independent charitable patient assistance prgrams (IPAPs) fcus n the needs f patients wh are insured, meet certain financial limitatin

More information

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states. Nvel methds and appraches fr sensing, evaluating, mdulating and regulating md and emtinal states. 2018 Jy Academic Grant Call fr Prpsals Intrductin The Annual Jy grant initiative aims t prmte and cntribute

More information

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)

More information

Specifically, on page 12 of the current evicore draft, we find the statement:

Specifically, on page 12 of the current evicore draft, we find the statement: Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit

More information

Corporate Governance Code for Funds: What Will it Mean?

Corporate Governance Code for Funds: What Will it Mean? Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface HTN-2 (NQF 0018): Cntrlling High Bld Pressure Measure Steward: NCQA CMS Web Interface V2.0 Page 1 f 18 11/13/2017 Cntents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4

More information

Indirect Sales. Proof Policy. Indirect Channel. Version May Author: Credit Risk & Fraud. External version

Indirect Sales. Proof Policy. Indirect Channel. Version May Author: Credit Risk & Fraud. External version Prf Plicy Indirect Channel Versin 12 7 May 2015 Authr: Credit Risk & Fraud External versin 1 Table f Cntents Intrductin... 3 Distance Selling... 4 Face t Face Selling... 10 Additinal Prfs Plicy Infrmatin...

More information

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...

More information

Radiographic Procedures I Laboratory. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses

Radiographic Procedures I Laboratory. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses SECTION A - Curse Infrmatin 1. Curse ID: 2. Curse Title: 3. Divisin: 4. Department: 5. Subject: 6. Shrt Curse Title: 7. Effective Term:: RAD 61C Radigraphic Prcedures I Labratry Technlgy and Health Divisin

More information

o Prostanoids/prostacyclin therapies (oral and inhaled) o Inhaled agents: Ventavis, Tyvaso Page 1 of 5 Revised 02/17/17

o Prostanoids/prostacyclin therapies (oral and inhaled) o Inhaled agents: Ventavis, Tyvaso Page 1 of 5 Revised 02/17/17 Request fr Prir Authrizatin Pulmnary Arterial Hypertensin (PAH) Agents (Oral and Inhaled) Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 All requests fr Pulmnary Arterial

More information

Medical Student Immunization Requirements

Medical Student Immunization Requirements Medical Student Immunizatin Requirements The State f Illinis cde, Reference: (110 ILCS 20) Cllege Student Immunizatin Act, requires students t prvide prf f immunity: Measles (Rubela), Mumps, Rubella (German

More information

2016 CWA Political Action Fund Administrative Procedures Checklist

2016 CWA Political Action Fund Administrative Procedures Checklist 2016 CWA Plitical Actin Fund Administrative Prcedures Checklist 1. Dates f Prgram The 2016 CWA Plitical Actin Fund (federal plitical actin cmmittee- CWA-COPE PCC) Prgram will be cnducted n a calendar year

More information

Kadcyla (ado-trastuzumab emtansine) Document Number: IC-0092

Kadcyla (ado-trastuzumab emtansine) Document Number: IC-0092 Kadcyla (ad-trastuzumab emtansine) Dcument Number: IC-0092 Last Review Date: 2/6/2018 Date f Origin: 05/16/2013 Dates Reviewed: 7/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014, 5/2015, 8/2015,

More information

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU

More information

Erythropoiesis Stimulating Agents (ESAs): Aranesp (darbepoetin alfa) Related Medical Guideline Off-Label Use of FDA-Approved Drugs and Biologicals

Erythropoiesis Stimulating Agents (ESAs): Aranesp (darbepoetin alfa) Related Medical Guideline Off-Label Use of FDA-Approved Drugs and Biologicals (Subcutaneus/Intravenus) Last Review Date: January 1, 2019 Number: MG.MM.PH.80 *NON-DIALYSIS* Medical Guideline Disclaimer C All rights reserved. The treating physician r primary care prvider must submit

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

ICD-10-CM Coding Basics Chapter Specifics

ICD-10-CM Coding Basics Chapter Specifics ICD-10-CM Cding Basics Chapter Specifics Chapter 15 Pregnancy, Childbirth and the Puerperium Vilma Smith, LVN, CPC, CCS Debra Bales, LVN, CPC Jnay Rischer, CPC 1 Rev. May 2015 ICD-10-CM Cnventins General

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information

Administrstrative Procedure

Administrstrative Procedure ELECTRONIC WORKING COPY VERIF. DATE: INITIALS: DIVISION: Envirnment, Safety, Health and Quality FUNCTIONAL AREA: Occupatinal Safety and Health SME: Garrick Schmburg Page 1 f 13 APPROVED BY/DATE: Steve

More information

Diabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring)

Diabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring) Rule Categry: Medical ` Ref: N: 2013-MN-0012 Versin Cntrl: Versin N. 1.1 Effective Date: December 2013 Revisin Date: December 2014 Diabetes Mellitus Lab Tests (Screening, Diagnsis & Mnitring) Adjudicatin

More information

LTCH QUALITY REPORTING PROGRAM

LTCH QUALITY REPORTING PROGRAM 4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04

More information

Yescarta (axicabtagene ciloleucel) (Intravenous)

Yescarta (axicabtagene ciloleucel) (Intravenous) Yescarta (axicabtagene cilleucel) (Intravenus) Last Review Date: 10/31/2017 Date f Origin: 10/31/2017 Dates Reviewed: 10/2017 Dcument Number: IC-0333 I. Length f Authrizatin Cverage will be prvided fr

More information

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

Ontario s Referral and Listing Criteria for Adult Lung Transplantation Ontari s Referral and Listing Criteria fr Adult Lung Transplantatin Versin 2.0 Trillium Gift f Life Netwrk Adult Lung Transplantatin Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient referral

More information

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL Cncussin awareness has increased significantly in recent years. The Natinal Cllegiate Athletic Assciatin (NCAA), Natinal Athletic Trainers Assciatin

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Folotyn (pralatrexate)

Folotyn (pralatrexate) Fltyn (pralatrexate) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Original Effective Date: 10/01/2015 Current Effective Date: 01/01/2018TBD03/01/2017 POLICY A. INDICATIONS The indicatins

More information

(Please text me on once you have submitted your request online and the cell number you used)

(Please text me on once you have submitted your request online and the cell number you used) Dear Thank yu fr yur email, nted. Belw steps n hw t register as a service prvider. Please nte that nce yu have requested t becme a service prvider, yu need t sms/what s up me n 0826392585, in rder t activate

More information

HIP REPLACEMENT SURGERY (ARTHROPLASTY)

HIP REPLACEMENT SURGERY (ARTHROPLASTY) Prtcl: ORT015 Effective Date: June 1, 2017 HIP REPLACEMENT SURGERY (ARTHROPLASTY) Table f Cntents Page COMMERCIAL & MEDICAID COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE... 3 U.S.FOOD AND DRUG ADMINISTRATION

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

Diabetes: HbA1c Poor Control (NQF 0059)

Diabetes: HbA1c Poor Control (NQF 0059) Diabetes: HbA1c Pr Cntrl (NQF 0059) EMeasure Name Diabetes: HbA1c Pr Cntrl EMeasure Id Pending Versin Number 1 Set Id Pending Available Date N infrmatin Measurement January 1, 20xx thrugh Perid December

More information

Lower Extremity Amputation (LEA) Considerations / Issues

Lower Extremity Amputation (LEA) Considerations / Issues Lwer Extremity Amputatin (LEA) Cnsideratins / Issues Prviding Te Fillers can be an advantageus resurce fr yur patient and business but it als cmes with certain cnsideratins. Please review this list belw

More information

Measure Specific Guidelines for Comprehensive Diabetes Care (CDC)

Measure Specific Guidelines for Comprehensive Diabetes Care (CDC) Measure Specific Guidelines fr Cmprehensive Diabetes Care (CDC) Descriptin: Members age 18-75 years f age with diabetes (Type 1 and Type 2)* that had all f the fllwing: *Members in hspice are excluded

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Statement of Work for Linked Data Consulting Services

Statement of Work for Linked Data Consulting Services A. Backgrund Infrmatin Statement f Wrk fr Linked Data Cnsulting Services The Natinal Library f Medicine (NLM), in Bethesda, Maryland, is a part f the Natinal Institutes f Health, US Department f Health

More information

Building Code 101 OWMC November 20, Ministry of Municipal Affairs and Housing

Building Code 101 OWMC November 20, Ministry of Municipal Affairs and Housing Building Cde 101 OWMC Nvember 20, 2015 Ministry f Municipal Affairs and Husing Disclaimer These slides are prvided by the Ministry f Municipal Affairs and Husing fr cnvenience nly The slides shuld nt be

More information

Immunisation and Disease Prevention Policy

Immunisation and Disease Prevention Policy Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

Introduction to Exercise Physiology HKIN 206 Human Kinetics Program. Course Outline

Introduction to Exercise Physiology HKIN 206 Human Kinetics Program. Course Outline Intrductin t Exercise Physilgy HKIN 206 Human Kinetics Prgram Curse Outline COURSE IMPLEMENTATION DATE: Pre 1998 OUTLINE EFFECTIVE DATE: September 2009 COURSE OUTLINE REVIEW DATE: August 2014 GENERAL COURSE

More information

Catherine Worthingham Fellows of APTA Instructions for Writing a Letter of Support

Catherine Worthingham Fellows of APTA Instructions for Writing a Letter of Support Catherine Wrthingham Fellws f APTA Instructins fr Writing a Letter f Supprt Fllwing is infrmatin designed t assist persns asked t write a letter f supprt fr a nminee fr the American Physical Therapy Assciatin

More information

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher: Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:

More information

Code of Conduct for Employees

Code of Conduct for Employees Crprate Human Resurces Plicy Cntent Updated: 2016-06-22 Wrk Envirnment Plicy N: HR-01-09 Page 1 f 5 Apprval: 2014-09-24 Cde f Cnduct fr Emplyees POLICY STATEMENT The residents and businesses f the City

More information

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit. Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial

More information

Guideline Number: NIA_CG_302 Last Revised Date: September 2015 Responsible Department: Implementation Date: September 2015 Clinical Operations

Guideline Number: NIA_CG_302 Last Revised Date: September 2015 Responsible Department: Implementation Date: September 2015 Clinical Operations Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT DENERVATION (RADIOFREQUENCY NEUROLYSIS) CPT Cdes: Cervical Thracic Regin: 64633, +64634 Lumbar Sacral Regin: 64635, +64636

More information

SCALES NW HEARING PROTECTION PROGRAM

SCALES NW HEARING PROTECTION PROGRAM PURPOSE Expsure t excessive nise in the wrkplace can cause permanent hearing lss. The Hearing Prtectin Prgram has been established t help ensure that emplyees f Scales NW, Inc. d nt suffer health effects

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-12 (NQF 0418): Preventive Care and Screening: Screening fr Depressin and Fllw-Up Measure Steward: CMS Web Interface V1.0 Page 1 f 22 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE

More information

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Vascular Imaging. EFFECTIVE JANUARY 1, 2019 Proprietary

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Vascular Imaging. EFFECTIVE JANUARY 1, 2019 Proprietary CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Apprpriate Use Criteria: Vascular Imaging EFFECTIVE JANUARY 1, 2019 Prprietary 8600 West Bryn Mawr Avenue Suth Twer Suite 800 Chicag, IL 60631 www.aimspecialtyhealth.cm

More information

MGPR Training Courses Guide

MGPR Training Courses Guide MGPR Training Curses Guide fiscal cde 92107050921 1. Descriptin The training prgram supprted by MGPR is prpsed by a grup f excellent mentrs/educatrs, accmplished in Pesticides Management and Analysis,

More information

Annual Principal Investigator Worksheet About Local Context

Annual Principal Investigator Worksheet About Local Context Cmpleting the NCI CIRB Annual Principal Investigatr Wrksheet Abut Lcal Cntext and the Study-Specific Wrksheet Abut Lcal Cntext at the University f Iwa All investigatrs cnducting research with the Natinal

More information

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1 Internatinal Myelma Wrking Grup Guidelines n Imaging Techniques in the Diagnsis and Mnitring f Multiple Myelma 1 Up t 90% f myelma patients develp stelytic lesins, a majr cause f mrbidity and mrtality,

More information